Barrington analyst Michael Petusky downgraded LeMaitre (LMAT) to Market Perform from Outperform without a price target following the Q4 report. The firm is making a valuation call. The shares have been on an “amazing run” since May 2023 but are “now very stretched,” the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LMAT:
- LeMaitre price target raised to $113 from $100 at Citizens JMP
- Lemaitre Vascular: Strong Financial Performance and Promising Prospects Justify Buy Rating and Raised Price Target
- LeMaitre Vascular Reports Strong Q4 2024 Results
- LeMaitre sees FY25 EPS $2.15-$2.32, consensus $2.16
- LeMaitre increases quarterly dividend 25% to 20c per share